These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 21542805)

  • 1. Oestrogen causes degradation of KLF5 by inducing the E3 ubiquitin ligase EFP in ER-positive breast cancer cells.
    Zhao KW; Sikriwal D; Dong X; Guo P; Sun X; Dong JT
    Biochem J; 2011 Jul; 437(2):323-33. PubMed ID: 21542805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oestrogen causes ATBF1 protein degradation through the oestrogen-responsive E3 ubiquitin ligase EFP.
    Dong XY; Fu X; Fan S; Guo P; Su D; Dong JT
    Biochem J; 2012 Jun; 444(3):581-90. PubMed ID: 22452784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Fbw7 tumor suppressor targets KLF5 for ubiquitin-mediated degradation and suppresses breast cell proliferation.
    Zhao D; Zheng HQ; Zhou Z; Chen C
    Cancer Res; 2010 Jun; 70(11):4728-38. PubMed ID: 20484041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efp targets 14-3-3 sigma for proteolysis and promotes breast tumour growth.
    Urano T; Saito T; Tsukui T; Fujita M; Hosoi T; Muramatsu M; Ouchi Y; Inoue S
    Nature; 2002 Jun; 417(6891):871-5. PubMed ID: 12075357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The E3 ubiquitin ligase SMAD ubiquitination regulatory factor 2 negatively regulates Krüppel-like factor 5 protein.
    Du JX; Hagos EG; Nandan MO; Bialkowska AB; Yu B; Yang VW
    J Biol Chem; 2011 Nov; 286(46):40354-64. PubMed ID: 21953463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TAZ antagonizes the WWP1-mediated KLF5 degradation and promotes breast cell proliferation and tumorigenesis.
    Zhao D; Zhi X; Zhou Z; Chen C
    Carcinogenesis; 2012 Jan; 33(1):59-67. PubMed ID: 22045023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen-induced interaction between KLF5 and estrogen receptor (ER) suppresses the function of ER in ER-positive breast cancer cells.
    Guo P; Dong XY; Zhao KW; Sun X; Li Q; Dong JT
    Int J Cancer; 2010 Jan; 126(1):81-9. PubMed ID: 19569049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efp promotes in vitro and in vivo growth of endometrial cancer cells along with the activation of nuclear factor-κB signaling.
    Sato W; Ikeda K; Urano T; Abe Y; Nakasato N; Horie-Inoue K; Takeda S; Inoue S
    PLoS One; 2018; 13(12):e0208351. PubMed ID: 30586414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human Kruppel-like factor 5 is a target of the E3 ubiquitin ligase WWP1 for proteolysis in epithelial cells.
    Chen C; Sun X; Guo P; Dong XY; Sethi P; Cheng X; Zhou J; Ling J; Simons JW; Lingrel JB; Dong JT
    J Biol Chem; 2005 Dec; 280(50):41553-61. PubMed ID: 16223724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The GPER1/SPOP axis mediates ubiquitination-dependent degradation of ERα to inhibit the growth of breast cancer induced by oestrogen.
    Zhang N; Sun P; Xu Y; Li H; Liu H; Wang L; Cao Y; Zhou K; TinghuaiWang
    Cancer Lett; 2021 Feb; 498():54-69. PubMed ID: 33069770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptomic analysis of hormone-sensitive patient-derived endometrial cancer spheroid culture defines Efp as a proliferation modulator.
    Yang C; Ikeda K; Horie-Inoue K; Sato W; Hasegawa K; Takeda S; Itakura A; Inoue S
    Biochem Biophys Res Commun; 2021 Apr; 548():204-210. PubMed ID: 33647797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteasomal degradation of the KLF5 transcription factor through a ubiquitin-independent pathway.
    Chen C; Zhou Z; Guo P; Dong JT
    FEBS Lett; 2007 Mar; 581(6):1124-30. PubMed ID: 17320083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Fbw7/human CDC4 tumor suppressor targets proproliferative factor KLF5 for ubiquitination and degradation through multiple phosphodegron motifs.
    Liu N; Li H; Li S; Shen M; Xiao N; Chen Y; Wang Y; Wang W; Wang R; Wang Q; Sun J; Wang P
    J Biol Chem; 2010 Jun; 285(24):18858-67. PubMed ID: 20388706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. YAP promotes breast cell proliferation and survival partially through stabilizing the KLF5 transcription factor.
    Zhi X; Zhao D; Zhou Z; Liu R; Chen C
    Am J Pathol; 2012 Jun; 180(6):2452-61. PubMed ID: 22632819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ligand-dependent transcription of estrogen receptor alpha is mediated by the ubiquitin ligase EFP.
    Nakajima A; Maruyama S; Bohgaki M; Miyajima N; Tsukiyama T; Sakuragi N; Hatakeyama S
    Biochem Biophys Res Commun; 2007 May; 357(1):245-51. PubMed ID: 17418098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ataxin-3 like (ATXN3L), a member of the Josephin family of deubiquitinating enzymes, promotes breast cancer proliferation by deubiquitinating Krüppel-like factor 5 (KLF5).
    Ge F; Chen W; Qin J; Zhou Z; Liu R; Liu L; Tan J; Zou T; Li H; Ren G; Chen C
    Oncotarget; 2015 Aug; 6(25):21369-78. PubMed ID: 26079537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efp/TRIM25 and Its Related Protein, TRIM47, in Hormone-Dependent Cancers.
    Azuma K; Inoue S
    Cells; 2022 Aug; 11(15):. PubMed ID: 35954308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Negative regulation of ISG15 E3 ligase EFP through its autoISGylation.
    Zou W; Wang J; Zhang DE
    Biochem Biophys Res Commun; 2007 Mar; 354(1):321-7. PubMed ID: 17222803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen regulates tumor growth through a nonclassical pathway that includes the transcription factors ERβ and KLF5.
    Nakajima Y; Akaogi K; Suzuki T; Osakabe A; Yamaguchi C; Sunahara N; Ishida J; Kako K; Ogawa S; Fujimura T; Homma Y; Fukamizu A; Murayama A; Kimura K; Inoue S; Yanagisawa J
    Sci Signal; 2011 Apr; 4(168):ra22. PubMed ID: 21487105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knockdown of ZBTB7A inhibits cell proliferation of breast cancer through regulating the ubiquitination of estrogen receptor alpha.
    Xiao X; Shen Y; Yin L; He J; Ni X; Luo G; Chen X; Zhu W; Zhong J; Liu J; Peng X; Zu X
    Life Sci; 2019 Dec; 239():117042. PubMed ID: 31715186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.